UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
32.10
+2.31 (7.75%)
Nov 19, 2026, 1:58 PM EST - Market open
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.57 billion as of November 19, 2026. It is the 7,459th most valuable company in the world and the 1,886th biggest in the United States. Its market cap has increased by 42.83% in one year.
Market Cap
1.57B
Enterprise Value
1.68B
1-Year Change
42.83%
Global Rank
Country Rank
#1,886 United States
Category
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.57B, an increase of 765.55%. That is a compound annual growth rate of 25.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 1.57B | 43.61% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.56B |
| Precigen | 1.54B |
| Braveheart Bio | 1.53B |
| Korsana Biosciences | 1.48B |
| ADARx Pharmaceuticals | 1.48B |
| uniQure | 1.46B |
| Immunocore Holdings | 1.44B |
| Rapport Therapeutics | 1.41B |